Search research articles
Contact Us
Filters
Showing results (1-10 of 51) with videos related to
Page
of 6
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 9, 2011
Targeting epidermal growth factor receptor to optimize chemoradiotherapy in locally advanced head and neck cancer: has biology been taken into account?
Daniel Herchenhorn, Carlos G Ferreira
Revista Do Hospital Das Clinicas
|
March 19, 2004
Advances in radiochemotherapy in the treatment of head and neck cancer
Daniel Herchenhorn, Fernando Luiz Dias
Clinics (Sao Paulo, Brazil)
|
April 24, 2012
Castration-resistant prostate cancer: systemic therapy in 2012
Fernando C Maluf, Oren Smaletz, Daniel Herchenhorn
Critical Reviews in Oncology/Hematology
|
March 17, 2021
Sequential therapies for advanced urothelial cancer: Hope meets new challenges
Daniel Herchenhorn, Vinicius Freire, Thamires Oliveira, et al.
Anti-Cancer Drugs
|
September 23, 2003
Fatal pulmonary toxicity in a patient treated with gefitinib for non-small cell lung cancer after previous hemolytic-uremic syndrome due to gemcitabine
Guilherme Rabinowits, Daniel Herchenhorn, Milton Rabinowits, et al.
Frontiers in Immunology
|
December 4, 2025
Safety and effectiveness of immune checkpoint inhibitors in patients with preexisting autoimmune diseases: a systematic review
Yasmim Dias, Viviane Silva, Maria Fernanda de Carvalho, et al.
Radiation Oncology (London, England)
|
March 8, 2022
Photobiomodulation as a treatment for dermatitis caused by chemoradiotherapy for squamous cell anal carcinoma: case report and literature review
Fabiana Hottz, Daniel Herchenhorn, Juliana Lenzi, et al.
Clinical Advances in Hematology & Oncology : H&O
|
August 2, 2023
New drug approvals in prostate cancer and their effect on the treatment landscape
Chinmay Jani, Nour Abdallah, Pavlina Chrysafi, et al.
Oncotargets and Therapy
|
October 8, 2016
Safety and efficacy of sunitinib in patients from Latin America: subanalysis of an expanded access trial in metastatic renal cell carcinoma
Carlos H Barrios, Daniel Herchenhorn, Matías Chacón, et al.
International Braz J Urol : Official Journal of the Brazilian Society of Urology
|
August 27, 2016
Sunitinib treatment in patients with advanced renal cell cancer: the Brazilian National Cancer Institute (INCA) experience
Rafael Corrêa Coelho, Tomás Reinert, Franz Campos, et al.
Page
of 6
Search research articles
Search
Showing results (1-10 of 51) with videos related to
Sort By:
Page
of 6
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 9, 2011
Targeting epidermal growth factor receptor to optimize chemoradiotherapy in locally advanced head and neck cancer: has biology been taken into account?
Daniel Herchenhorn, Carlos G Ferreira
Revista Do Hospital Das Clinicas
|
March 19, 2004
Advances in radiochemotherapy in the treatment of head and neck cancer
Daniel Herchenhorn, Fernando Luiz Dias
Clinics (Sao Paulo, Brazil)
|
April 24, 2012
Castration-resistant prostate cancer: systemic therapy in 2012
Fernando C Maluf, Oren Smaletz, Daniel Herchenhorn
Critical Reviews in Oncology/Hematology
|
March 17, 2021
Sequential therapies for advanced urothelial cancer: Hope meets new challenges
Daniel Herchenhorn, Vinicius Freire, Thamires Oliveira, et al.
Anti-Cancer Drugs
|
September 23, 2003
Fatal pulmonary toxicity in a patient treated with gefitinib for non-small cell lung cancer after previous hemolytic-uremic syndrome due to gemcitabine
Guilherme Rabinowits, Daniel Herchenhorn, Milton Rabinowits, et al.
Frontiers in Immunology
|
December 4, 2025
Safety and effectiveness of immune checkpoint inhibitors in patients with preexisting autoimmune diseases: a systematic review
Yasmim Dias, Viviane Silva, Maria Fernanda de Carvalho, et al.
Radiation Oncology (London, England)
|
March 8, 2022
Photobiomodulation as a treatment for dermatitis caused by chemoradiotherapy for squamous cell anal carcinoma: case report and literature review
Fabiana Hottz, Daniel Herchenhorn, Juliana Lenzi, et al.
Clinical Advances in Hematology & Oncology : H&O
|
August 2, 2023
New drug approvals in prostate cancer and their effect on the treatment landscape
Chinmay Jani, Nour Abdallah, Pavlina Chrysafi, et al.
Oncotargets and Therapy
|
October 8, 2016
Safety and efficacy of sunitinib in patients from Latin America: subanalysis of an expanded access trial in metastatic renal cell carcinoma
Carlos H Barrios, Daniel Herchenhorn, Matías Chacón, et al.
International Braz J Urol : Official Journal of the Brazilian Society of Urology
|
August 27, 2016
Sunitinib treatment in patients with advanced renal cell cancer: the Brazilian National Cancer Institute (INCA) experience
Rafael Corrêa Coelho, Tomás Reinert, Franz Campos, et al.
Page
of 6